This creates a vicious cycle: stress raises cortisol, cortisol drives weight gain and appetite, and impaired GLP-1 signaling perpetuates the problem
On the other hand, Wegovy is started on a lower dose of 0.25mg subcutaneously once weekly and this dosage increases every four weeks by an additional .25mg until reaching its maximum dose of 2.4mg/week for chronic weight management in adult patients who are overweight or obese
And again, we didnt even have this technology that, you know, 15, 20 years ago
It's missing ACV for blood sugar balance, prebiotics for gut-brain signaling, and several other compounds that create synergistic GLP-1 support
Bazhu Decoction reduced cognitive and anxiety impairments by inhibiting BACE1 and PS1-NTF protein levels, leading to reduced APP processing and reduced oxidative stress markers
The catalog number to use will depend on the specific application